Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterizations of enhanced infectivity and antibody evasion of Omicron BA.2.75
Yunlong Cao, Weiliang Song, Lei Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 189-199
Open Access | Times Cited: 272
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies
MacGregor Cox, Thomas P. Peacock, William T. Harvey, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 2, pp. 112-124
Open Access | Times Cited: 261
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 212
Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains
Tyler N. Starr, Allison J. Greaney, Cameron Stewart, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 11, pp. e1010951-e1010951
Open Access | Times Cited: 163
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
Akatsuki Saito, Tomokazu Tamura, Jiří Zahradník, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 11, pp. 1540-1555.e15
Open Access | Times Cited: 148
Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA.4/5/2.75 subvariants in BA.2 breakthrough infections
Bin Ju, Qing Fan, Miao Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
Henning Gruell, Kanika Vanshylla, Pinkus Tober‐Lau, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 10, pp. 1422-1423
Open Access | Times Cited: 31
Omicron BA.2.75 Subvariant of SARS-CoV-2 Is Expected to Have the Greatest Infectivity Compared with the Competing BA.2 and BA.5, Due to Most Negative Gibbs Energy of Binding
Marko Popovic
BioTech (2022) Vol. 11, Iss. 4, pp. 45-45
Open Access | Times Cited: 29
Viral load decrease in SARS‐CoV‐2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents
Valentina Mazzotta, Alessandro Cozzi Lepri, Francesca Colavita, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 27
The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review
Ranjan K. Mohapatra, Sarika Verma, Venkataramana Kandi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Open Access | Times Cited: 16
An Early and Preliminary Assessment of the Clinical Severity of the Emerging SARS-CoV-2 Omicron Variants in Maharashtra, India
Rajesh Karyakarte, Rashmita Das, Nyabom Taji, et al.
Cureus (2022)
Open Access | Times Cited: 23
Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains
Tyler N. Starr, Allison J. Greaney, Cameron Stewart, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 19
Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
Xun Wang, Jingwen Ai, Xiangnan Li, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Will ‘Centaurus’ be the next global coronavirus variant? Indian cases offers clues
Ewen Callaway
Nature (2022) Vol. 608, Iss. 7923, pp. 462-463
Open Access | Times Cited: 15
Mutational characterization of Omicron SARS-CoV-2 lineages circulating in Chhattisgarh, a central state of India
Pushpendra Singh, Kuldeep Sharma, Dipika Shaw, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 8
SARS-CoV-2 Pre-Exposure Prophylaxis with Sotrovimab and Tixagevimab/Cilgavimab in Immunocompromised Patients—A Single-Center Experience
David Totschnig, Max Augustin, I Niculescu, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2278-2278
Open Access | Times Cited: 12
The Omicron-transformer: Rise of the subvariants in the age of vaccines
Travis Ren Teen Chia, Barnaby Edward Young, Po Ying Chia
Annals of the Academy of Medicine Singapore (2022) Vol. 51, Iss. 11, pp. 712-729
Open Access | Times Cited: 10
Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney Diseases
Daniel Leung, Eugene Yu-hin Chan, Xiaofeng Mu, et al.
Kidney International Reports (2023) Vol. 8, Iss. 11, pp. 2356-2367
Open Access | Times Cited: 5
Characterization and Distribution of SARS-CoV-2 Omicron Variant and its Sub-lineages in Uttarakhand using Next Generation Sequencing: A Retrospective Study
Shekhar Pal, Geetika Rana, S.P. Singhal, et al.
Journal of Pure and Applied Microbiology (2024) Vol. 18, Iss. 1, pp. 682-695
Open Access | Times Cited: 1
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
Ryuta Uraki, Shun Iida, Peter Halfmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Genomic surveillance of SARS-CoV-2 upsurge in India due to Omicron sub-lineages BA.2.74, BA.2.75 and BA.2.76
Urvashi B. Singh, Sushanta Deb, Lata Rani, et al.
The Lancet Regional Health - Southeast Asia (2023) Vol. 11, pp. 100148-100148
Open Access | Times Cited: 4
Evasion of Neutralizing Antibody Response by the SARS-CoV-2 BA.2.75 Variant
Panke Qu, John P. Evans, Yi-Min Zheng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Neutralization of Omicron BA.4/BA.5 and BA.2.75 by Booster Vaccination or BA.2 Breakthrough Infection Sera
Xun Wang, Jingwen Ai, Xiangnan Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
An Early and Preliminary Assessment of the Clinical Severity of the Emerging SARS-CoV-2 Omicron Variants in Maharashtra, India
Rajesh Karyakarte, Rashmita Das, Nyabom Taji, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Humoral and Cellular Immunogenicity and Safety of 3 Doses of CoronaVac and BNT162b2 in Young Children and Adolescents with Kidney Diseases
Daniel Leung, Eugene Yu-hin Chan, Xiaofeng Mu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top